COMP <GO>
SHC vs PGNY // REVENUE GROWTH (YOY)
Sotera Health Company (NASDAQ) VS. Progyny Inc. (NASDAQ) • 15-METRIC TALLY: SHC 5
— PGNY 7
▲ REVENUE GROWTH (YOY) LEADER: PGNY
LAST: $18.70 (+0.27%) • MKT CAP: $5.34B
revenue-growth
5.70%
LAST: $28.40 (+1.90%) • MKT CAP: $2.18B
revenue-growth
10.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SHC VS. PGNY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SHC | PGNY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.50% | 23.60% | +31.90 | SHC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 16.70% | -13.60 | PGNY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 33.5x | 20.5x | +13.00 | PGNY | /valuation <GO> |
| Free Cash Flow Yield | 2.80% | 8.80% | -6.00 | PGNY | /fcf-yield <GO> |
| Operating Margin | 8.20% | 6.60% | +1.60 | SHC | /operating-margins <GO> |
| Net Profit Margin | 6.70% | 4.50% | +2.20 | SHC | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 5.70% | 10.40% | -4.70 | PGNY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.56 | 8.84 | -7.28 | PGNY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | SHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.2 | 62.0 | -5.82 | PGNY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 63.7x | 34.6x | +29.10 | PGNY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.34B | $2.18B | $3.16B | SHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SHC REV | PGNY REV | SHC GROSS % | PGNY GROSS % | SHC FCF | PGNY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.16B | $1.29B | 55.5% | 23.6% | $149.2M | $191.8M |
| FY 2024 | $1.10B | $1.17B | 54.7% | 21.7% | $45.1M | $173.7M |
| FY 2023 | $1.05B | $1.09B | — | — | -$194.9M | $188.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SHC // BETA 1.10
PGNY // BETA —